Science Publishing Mega-Merger

Macmillan Science and Education, the publisher of Nature and Scientific American, will join forces with Springer Science+Business Media.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, NEW ZEALAND TRANSPORT AGENCYThe London-based publisher of venerated scientific journal Nature has plans to merge with one of the largest science publishers in the world, according to the two firms’ parent companies. Macmillan Science and Education, which publishes Scientific American as well as Nature, announced on Thursday (January 15) that it will merge with Berlin-based Springer Science+Business Media, the publisher of the Journal of Molecular Medicine, Clinical Pharmacokinetics, and Acta Neuropathologica, among many other titles. The merger, which still has to clear European competition regulators, was struck between Holtzbrinck Publishing Group, owner of Macmillan, and private equity firm BC Partners, which bought out Springer in 2013.

“The deal makes a lot of sense for both sides,” Claudio Aspesi, a media analyst with Sanford C. Bernstein & Co. in London, told Nature. “From BC Partners’ perspective, there were a lot of questions about what they could do with Springer when they bought it, since much cost-cutting had already been done. Now we know how you can add value to that deal — add the most prestigious journals in the world. For Holtzbrinck, the idea is presumably that they get additional scale for Macmillan, which will give additional funds for any new plans.”

Springer is a giant in the academic publishing world, hosting almost 3,000 titles. Macmillan only publishes 160 journals, but among them are Nature and the associated research journals. “Combined, these ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo